AmpliPhi Bio To Participate In Upcoming Conferences
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced that company management will participate in two upcoming scientific and investor conferences: